Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 7,906 shares at $34.24 ($268K) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Open-market sale of $268k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.46 | 1,567 | $52K | 19.5% |
| 2 | $33.46 | 1,567 | $52K | 19.5% |
| 3 | $34.24 | 2,261 | $77K | 28.8% |
| 4 | $34.24 | 2,261 | $77K | 28.8% |
| 5 | $35.01 | 250 | $9K | 3.3% |
| Total | $33.96 avg | 7,906 |
| $268K |
| 100% |
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |